Clinical Trial Update: Metyrapone for Mild Autonomous Cortisol Secretion (MACS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metyrapone for mild autonomous cortisol secretion (MACS) is active but not recruiting, sponsored by Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomous Cortisol Secretion

Drugs mentioned

• Metopirone (metyrapone)

Snippet

Sponsor: Mayo Clinic | Conditions: Autonomous Cortisol Secretion, Mild Autonomous Cortisol Secretion (MACS) | Phase 2 | Status: ACTIVE_NOT_RECRUITING